Literature DB >> 21482858

Iridocorneal endothelial syndrome masquerading as iris melanoma in 71 cases.

Carol L Shields1, Margaret V Shields, Vanessa Viloria, Haley Pearlstein, Emil Anthony T Say, Jerry A Shields.   

Abstract

OBJECTIVE: To describe the clinical features of iridocorneal endothelial (ICE) syndrome in a group of patients referred because of suspected iris melanoma.
METHODS: In a noncomparative case series, we performed medical record review for clinical features of ICE syndrome in 71 patients.
RESULTS: At presentation, the median patient age was 54 years. All patients were referred for evaluation of a pigmented iris mass, suspected to be a melanoma. The iris color was blue or green in 51 (72%) and brown in 20 (28%). The mass proved to be a combination of iris stromal atrophy in 41 cases (58%) with exposure or loss of the underlying iris pigment epithelium; ectropion iridis in 24 (34%), imparting a disfigured iris with dark-brown color; iris nodules in 5 (7%); traction elevation with iris distortion from peripheral anterior synechia in 57 (80%); and corectopia in 53 (75%), a feature commonly found with iris melanoma. The mean extent of iris atrophy was 2 clock hours. Ectropion iridis was unidirectional in 10 and multidirectional in 14. Additional features of ICE included corneal endothelial guttata-like changes in 33 (46%), corneal edema in 7 (10%), iris pigment epithelial transillumination defects in 12 (17%), polycoria in 1 (1%), and secondary glaucoma with intraocular pressure higher than 22 mm Hg in 7 (10%).
CONCLUSIONS: Iridocorneal endothelial syndrome can simulate iris melanoma. Features more suggestive of ICE syndrome include corneal endothelial guttata-like changes and edema, peripheral anterior synechia, multidirectional ectropion iridis, and iris atrophy.

Entities:  

Mesh:

Year:  2011        PMID: 21482858     DOI: 10.1001/archophthalmol.2011.70

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Concurrence of iridocorneal endothelial syndrome in a patient with glaucomatocyclitic crisis.

Authors:  Jin A Choi; Yi Ryeung Park; Tae Yoon La
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

2.  Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China.

Authors:  Mengze Hao; Gang Zhao; Xiaoling Du; Yun Yang; Jilong Yang
Journal:  Tumour Biol       Date:  2016-02-04

3.  Commentary: In vivo confocal microscopy in iridocorneal endothelial syndrome.

Authors:  Vineet Ratra
Journal:  Indian J Ophthalmol       Date:  2019-05       Impact factor: 1.848

Review 4.  Diagnosis and Management of Pseudoguttata: A Literature Review.

Authors:  Majid Moshirfar; Harry Y Liu; Uma Vaidyanathan; Anisha N Somani; Grant C Hopping; James R Barnes; Madeline B Heiland; David B Rosen; Mahsaw N Motlagh; Phillip C Hoopes
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019

Review 5.  Diagnosis and Management of Iridocorneal Endothelial Syndrome.

Authors:  Marta Sacchetti; Flavio Mantelli; Marco Marenco; Ilaria Macchi; Oriella Ambrosio; Paolo Rama
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

Review 6.  Review of cystic and solid tumors of the iris.

Authors:  Carol L Shields; Patrick W Shields; Janet Manalac; Chaisiri Jumroendararasame; Jerry A Shields
Journal:  Oman J Ophthalmol       Date:  2013-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.